Medexus Pharmaceuticals Inc. (MEDXF) PT Lowered to $7 at Roth Capital
Tweet
Share
E-mailGet Alerts MEDXF Hot Sheet
Price: $3.83 -0.78%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Roth Capital analyst Scott Henry lowered the price target on Medexus Pharmaceuticals Inc. (OTC: MEDXF) to $7.00 (from $8.00) while maintaining a Buy rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
